Summit Investment Advisors »

Contineum Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $13k 680 19.14
2024-06-30 $12k 680 17.61